Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-infiltrating dendritic cell states are conserved across solid human cancers
Genevieve M. Gerhard, Ruben Bill, Marius Messemaker, et al.
The Journal of Experimental Medicine (2020) Vol. 218, Iss. 1
Open Access | Times Cited: 190

Showing 1-25 of 190 citing articles:

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1539
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Ilio Vitale, Efrat Shema, Sherene Loi, et al.
Nature Medicine (2021) Vol. 27, Iss. 2, pp. 212-224
Closed Access | Times Cited: 571
Clinical relevance of tumour-associated macrophages
Mikaël J. Pittet, Olivier Michielin, Denis Migliorini
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 402-421
Closed Access | Times Cited: 460
CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment
Mauro Di Pilato, Raphael Kfuri-Rubens, Jasper N. Pruessmann, et al.
Cell (2021) Vol. 184, Iss. 17, pp. 4512-4530.e22
Open Access | Times Cited: 310
Dendritic cell subsets in cancer immunity and tumor antigen sensing
Annalisa Del Prete, Valentina Salvi, Alessandra Soriani, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 5, pp. 432-447
Open Access | Times Cited: 271
CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers
Ruben Bill, Pratyaksha Wirapati, Marius Messemaker, et al.
Science (2023) Vol. 381, Iss. 6657, pp. 515-524
Open Access | Times Cited: 236
Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity
Ellen Duong, Tim Fessenden, Emi A. Lutz, et al.
Immunity (2021) Vol. 55, Iss. 2, pp. 308-323.e9
Open Access | Times Cited: 222
A neutrophil response linked to tumor control in immunotherapy
Jeremy Gungabeesoon, Nicolas A. Gort-Freitas, Máté Kiss, et al.
Cell (2023) Vol. 186, Iss. 7, pp. 1448-1464.e20
Closed Access | Times Cited: 203
The role of dendritic cells in cancer and anti-tumor immunity
Ariel E. Marciscano, Niroshana Anandasabapathy
Seminars in Immunology (2021) Vol. 52, pp. 101481-101481
Open Access | Times Cited: 170
Human dendritic cells in cancer
Egle Kvedaraite, Florent Ginhoux
Science Immunology (2022) Vol. 7, Iss. 70
Closed Access | Times Cited: 165
Single-cell analysis of human skin identifies CD14+ type 3 dendritic cells co-producing IL1B and IL23A in psoriasis
Satoshi Nakamizo, Charles‐Antoine Dutertre, Ahad Khalilnezhad, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 9
Open Access | Times Cited: 105
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 105
Immune regulation through tryptophan metabolism
Su‐Kil Seo, Byungsuk Kwon
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1371-1379
Open Access | Times Cited: 103
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
Raquel S. Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 93
Dendritic cells as shepherds of T cell immunity in cancer
Mikaël J. Pittet, Mauro Di Pilato, Christopher Garris, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2218-2230
Open Access | Times Cited: 92
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy
Vipul Bhatia, Nikhil Kamat, Tiffany E. Pariva, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 55
Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): A novel population in the tumour microenvironment and immunotherapy target
Jiaxin Li, Jun Zhou, Huanhuan Huang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 48
CD4+ helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment
Xin Lei, Indu Khatri, Tom de Wit, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
cis-B7:CD28 interactions at invaginated synaptic membranes provide CD28 co-stimulation and promote CD8+ T cell function and anti-tumor immunity
Yunlong Zhao, Christine Caron, Ya-Yuan Chan, et al.
Immunity (2023) Vol. 56, Iss. 6, pp. 1187-1203.e12
Closed Access | Times Cited: 42
Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer
Stephen L. Shiao, Kenneth Gouin, Nathan Ing, et al.
Cancer Cell (2024) Vol. 42, Iss. 1, pp. 70-84.e8
Closed Access | Times Cited: 40
Cholesterol mobilization regulates dendritic cell maturation and the immunogenic response to cancer
Meriem Belabed, Matthew D. Park, Cédric M. Blouin, et al.
Nature Immunology (2025)
Closed Access | Times Cited: 3
Lactobacillus intestinalis facilitates tumor-derived CCL5 to recruit dendritic cell and suppress colorectal tumorigenesis
Yong Sun, Qiwen Wang, Yao Jiang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Dendritic cell maturation in cancer
Chang Moon, Meriem Belabed, Matthew D. Park, et al.
Nature reviews. Cancer (2025)
Closed Access | Times Cited: 2
Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy
William W. Ho, Igor L. Gomes‐Santos, Shuichi Aoki, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 45
Open Access | Times Cited: 64
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy
Marie Siwicki, Nicolas A. Gort-Freitas, Marius Messemaker, et al.
Science Immunology (2021) Vol. 6, Iss. 61
Open Access | Times Cited: 63
Page 1 - Next Page

Scroll to top